Home » Stocks » Mesa Laboratories

Mesa Laboratories, Inc. (MLAB)

Stock Price: $242.31 USD -5.08 (-2.05%)
Updated Aug 14, 2020 4:00 PM EDT - Market closed
After-hours: $242.30 -0.01 (0.00%) Aug 14, 4:00 PM

Stock Price Chart

Key Info

Market Cap 1.24B
Revenue (ttm) 121.34M
Net Income (ttm) -2.22M
Shares Out 5.10M
EPS (ttm) -0.51
PE Ratio n/a
Forward PE 36.76
Dividend $0.64
Dividend Yield 0.26%

Stock Quote

Trading Day Aug 14, 2020
Last Price $242.31
Previous Close $247.39
Change ($) -5.08
Change (%) -2.05%
Day's Open 246.73
Day's Range 242.09 - 248.20
Day's Volume 29,775
52-Week Range 181.90 - 271.46

More Stats

Market Cap 1.24B
Enterprise Value 1.15B
Earnings Date (est) Nov 9, 2020
Ex-Dividend Date May 28, 2020
Shares Outstanding 5.10M
Float 4.79M
EPS (basic) -0.5
EPS (diluted) -0.51
FCF / Share 5.84
Dividend $0.64
Dividend Yield 0.26%
Earnings Yield n/a
FCF Yield 2.14%
Payout Ratio n/a
Shares Short 384,330
Short Ratio 9.79
Short % of Float 8.71%
Beta 0.38
PE Ratio n/a
Forward PE 36.76
P/FCF Ratio 46.79
PS Ratio 10.19
PB Ratio 3.36
Revenue 121.34M
Operating Income 4.89M
Net Income -2.22M
Free Cash Flow 26.43M
Net Cash 89.35M
Net Cash / Share 17.51
Gross Margin 60.52%
Operating Margin 4.03%
Profit Margin -1.80%
FCF Margin 21.78%
ROA 2.57%
ROE -0.89%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (3)

Buy 2
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(8.82% upside)
Current: $242.31
Target: 263.67
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth14.11%7.23%2.68%10.64%18.69%35.29%13.54%17.21%15.74%-
Gross Profit64.9360.9254.6253.2451.4143.3931.6928.8623.5119.57
Operating Income7.9810.342.1516.3116.3215.8611.7913.1012.489.86
Net Income1.357.48-2.9611.1811.179.589.008.457.926.18
Shares Outstanding4.203.843.773.683.613.523.453.363.293.23
Earnings Per Share0.311.86-0.792.912.972.632.492.352.291.86
EPS Growth-83.33%---2.02%12.93%5.62%5.96%2.62%23.12%-
Dividend Per Share0.640.480.640.640.640.620.580.540.500.46
Dividend Growth33.33%-25%0%0%3.23%6.9%7.41%8%8.7%-
Operating Cash Flow26.5630.5525.7217.3016.9010.8212.3711.4012.498.87
Capital Expenditures-1.480.96-1.67-11.61-7.73-2.83-1.04-0.91-0.68-2.65
Free Cash Flow25.0831.5124.055.709.177.9911.3310.4911.816.22
Cash & Equivalents81.3810.195.475.825.702.035.584.017.193.55
Total Debt14022.7446.2654.8045.2526.2516.504.00-6.50
Net Cash / Debt-58.90-12.55-40.79-48.98-39.56-24.22-10.930.017.19-2.95
Book Value22011199.3697.8284.6873.4864.3352.7543.9236.42
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Mesa Laboratories, Inc.
Country United States
Employees 460
CEO Gary M. Owens

Stock Information

Ticker Symbol MLAB
Stock Exchange NASDAQ
Sector Technology
Industry Scientific & Technical Instruments
Unique Identifier NASDAQ: MLAB


Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Canada, Europe, and Japan. The company's Sterilization and Disinfection Control segment manufactures and markets biological indicators comprising spore strips, self-contained products, and culture media, as well as process challenge devices; and offers testing services. This segment also provides chemical and cleaning indicators that are used to assess the effectiveness of sterilization and cleaning processes. Its Instruments segment offers data loggers used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air sampling; and torque testing systems used for measure bottle cap tightness. This segment's products are used in healthcare, pharmaceutical, medical device, food and beverage, industrial hygiene, and environmental air sampling industries. The company's Biopharmaceutical Development segment develops, manufactures, and commercializes automated solutions for protein analysis, which include analysis equipment, CDs, kits, and buffers; and peptide synthesizers to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. Its Continuous Monitoring segment offers systems, which are used to monitor temperature, humidity, and differential pressure for use in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and laboratory environments. The company was founded in 1982 and is headquartered in Lakewood, Colorado.